Data Quality and Technology in Clinical Trials 2016

Topics

• Become a data company: Work with pharma’s leaders to design the analytics-driven organization of the future
• Maximize data quality: Enhance your trial rate of success with the perfect protocol design
• Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring
• Harness the right analytics: Translate and adopt the hidden message behind your data
• Why Attend?
• Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange
• An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives
• First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines
• Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization
• Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques

Who should Attend

Senior attendees with responsibilities in:

• Clinical Innovation
• Global Clinical Trial Operations
• Clinical Projects & Quantitative Sciences
• Information Strategy and Analytics
• Study Data Management
• Early Development Operation
• R&D Information Strategy and Analytics
• Information Strategy and Analytics
• Data Acquisition Services
• Clinical Development Information & Optimization
• Data Acquisition Services
• Global Data Sciences and Analytics
• Global Regulatory Affairs